RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

IMS Health Incorporated

A collection of news and information related to IMS Health Incorporated published by this site and its partners.

Top IMS Health Incorporated Articles

Displaying items 23-29
  • FDA: Avandia Should Stay With Restrictions

    FDA: Avandia Should Stay With Restrictions
    Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
  • Brain shrinkage seen in those taking antipsychotic medications

    A new study finds that one the fastest-growing classes of prescription drugs in the United States is linked to shrinkage in the brains of those who take it, raising some new questions about the widening use of antipsychotic medications.       Over a...
  • Glaxo adds safety restrictions to Avandia label

    Glaxo adds safety restrictions to Avandia label
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...
  • Effectiveness of statins called into question

    Effectiveness of statins called into question
    As the world's most-prescribed class of medications, statins indisputably qualify for the commercial distinction of "blockbuster." About 24 million Americans take the drugs — marketed under such commercial names as Pravachol, Mevacor, Lipitor, Zocor...
  • Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns

    Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns
    About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...
  • Newer antipsychotics overused, US study suggests

    Newer antipsychotics overused, US study suggests
    Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday. The drugs, known as "atypical...
  • The FDA requires a black-box warning on anti-clotting drug Plavix

     
    The Food and Drug Administration said Friday that it will require a new black-box warning on the label of the popular anti-clotting drug Plavix to indicate that some patients do not metabolize the drug properly and may receive little benefit......